246
Participants
Start Date
February 28, 2010
Primary Completion Date
August 31, 2010
Study Completion Date
August 31, 2010
Canakinumab 150 mg
Single subcutaneous injection of Canakinumab 150 mg.
Placebo to Canakinumab
Single subcutaneous injection of Placebo to Canakinumab.
National Research Institute, Los Angeles
Crest Clinical Trials, Santa Ana
Encompass Clinical Research, Spring Valley
Commonwealth Biomedical Research LLC, Madisonville
University of Nebraska Medical Center, Omaha
VA Medical Center, Omaha
Lillestol Research LLC, Fargo
Preferred Primary Care Physicians, Pittsburgh
Dallas Diabetes and Endocrine Center, Dallas
Texas Center for Drug Development P.A., Houston
Utah Clinical Trials, Salt Lake City
Barwon Health - Geelong Hospital, Geelong
Austin Health - Heidelberg Repatriation Hospital, Heidelberg Heights
Melbourne Health - Royal Melbourne Hospital, Melbourne
Lifestyle Metabolism Centre (Etobicoke), Etobicoke
LMC Endocrinology Centres (Markham) Ltd, Markham
LMC Endocrinology Centres (Thornhill) Ltd, Thornhill
Centre de recherche clinique de Laval, Laval
Hôpital Maisonneuve-Rosemont, Montreal
Lihavuustutkimusyksikkö, Helsinki
Lääkärikeskus Mehiläinen Töölö, Helsinki
ODL Terveys Oy, Oulu
Clintrial Berlin Praxis fuer medizinische Studien, Berlin
Klinische Forschung Berlin-Buch Dr. Andrei Khariouzov, Berlin
Gemeinschaftspraxis Dr. Ingo Zeissig, Duisburg
"Sana Krankenhaus Gerresheim", Düsseldorf
Praxis Dr. Thorsten Rau, Essen
Praxis Dr. med. Joerg Luedemann, Falkensee
Dr. Helmut Anderten Gemeinschaftspraxis Dres. Anderten und Krok, Hildesheim
Praxis Dr. Julia Chevts, Karlsruhe
Pro Scientia Med, Lübeck
Praxis Dr. Winfried Keuthage, Münster
Praxis Dr. Uwe Boeckmann, Neumünster
Dr. Klaus Funke IkFE Studiencenter Potsdam GMBH I.G., Potsdam
Praxis Dr. Gerhard Steinmaier, Viernheim
Praxis Dr. Reinhold U. Schneider, Wetzlar-Naunheim
Visakha Diabetes & Endocrine Centre, Visakhapatnam
Jnana Sanjeevini Medical Center, Bangalore
Bangalore Diabetes Hospital,, Banglore
Health & Research Centre, Trivandrum
Diabetes Thyroid Hormone Research Institute Pvt .Ltd., Indore
Indrayani Speciality Hospital,, Nagpur
Sahyadri Hospital Bibewewadi Centre of Excellence for Diabetics, Pune
Madras Diabetes Research Foundation, Chennai
Azienda Ospedaliera-Ospedali Riuniti di BergamoU, Bergamo
Az. Ospedaliera Universit. S.Martino-Universita degli Studi, Genova
Azienda Ospedaliera S. Paolo-Polo Universitario, Milan
Fondazione Centro San Raffaele del Monte Tabor-IRCCSUnità, Milan
Az. Ospedaliera Della Prov.di Pavia, Casorate Primo
Policlinico A.Gemelli - Univ.Cattolica del Sacro Cuore, Roma
A.O.Universitaria Senese, Universita degli Studi di Siena, Siena
S.C.D.U. Endocrinologia e Malattie del Metabolismo, Torino
Lead Sponsor
Novartis
INDUSTRY